CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $204,256 | +10.8% | 6,935 | +27.0% | 0.00% | – |
| Q2 2023 | $184,264 | +1.2% | 5,461 | +5.3% | 0.00% | – |
| Q1 2023 | $182,110 | -24.6% | 5,187 | -1.9% | 0.00% | – |
| Q4 2022 | $241,558 | -48.3% | 5,286 | -45.1% | 0.00% | -100.0% |
| Q3 2022 | $467,000 | -52.9% | 9,633 | -61.8% | 0.00% | -50.0% |
| Q2 2022 | $992,000 | +544.2% | 25,186 | +324.7% | 0.00% | – |
| Q1 2022 | $154,000 | -34.5% | 5,930 | +14.9% | 0.00% | – |
| Q4 2021 | $235,000 | +55.6% | 5,163 | +23.4% | 0.00% | – |
| Q3 2021 | $151,000 | +81.9% | 4,184 | +2.1% | 0.00% | – |
| Q2 2021 | $83,000 | -9.8% | 4,097 | +5.0% | 0.00% | – |
| Q1 2021 | $92,000 | +67.3% | 3,901 | +43.2% | 0.00% | – |
| Q4 2020 | $55,000 | +66.7% | 2,725 | +97.0% | 0.00% | – |
| Q3 2020 | $33,000 | 0.0% | 1,383 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | +83.3% | 1,383 | -7.1% | 0.00% | – |
| Q1 2020 | $18,000 | – | 1,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |